Tirzepatide is one of the most studied compounds in research on metabolic regulation, energy balance and appetite control. Its peptide structure acts simultaneously on two hormone receptors — GIP and GLP-1 — making it one of the compounds of greatest interest in metabolic research models over the last decade.

The GLP-1 receptor (glucagon-like peptide-1) is associated with the regulation of satiety, slowing of gastric emptying and satiety signalling to the central nervous system. The GIP receptor (glucose-dependent insulinotropic polypeptide) is involved in glucose utilisation and post-prandial energy balance. The simultaneous activation of these two receptors is what sets Tirzepatide apart from other compounds in the same class in comparative studies.

This product is intended exclusively for in vitro scientific research. It is not a medicine. It is not intended for human or veterinary use. Handling must be carried out by qualified professionals in a suitable laboratory environment, following good research practice. FOR RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION.